Skip to main content
ABCL filings

Corporate insider profile

Andrew Booth Filing Activity

Latest reported as Chief Financial Officer of AbCellera Biologics Inc. (ABCL).

Purchase filings
1
Reported companies
1
Net open-market value
$383,904
Latest transaction
Aug 14, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Aug 14, 2026AbCellera Biologics Inc. (ABCL)Chief Financial OfficerOpen Market Purchase37,200$10.32$383,904